MediFormatica’s Post

As private equity dealmakers gear up for a more promising 2024 in health care M&A, several key insights have emerged: 🔹 The bid-ask spread is finally closing, hinting at a more optimistic outlook for health care dealmaking this year. 🔹 Limited Partners (LPs) are emphasizing Distributed to Paid-In Capital (DPI), emphasizing the importance of returning money to investors amid slower dry powder deployment. 🔹 Regulatory scrutiny has increased, and is impacting both PE and strategics. 🔹 Many companies faced broken deal processes in 2023, leading to a cautious approach in the current market. 🔹 Co-investing is expected to persist as a strategy to bridge the bid-ask gap and generate returns for investors. Dealmakers should navigate regulatory complexities while simultaneously seizing the strategic investment avenues available within this 2024 health care M&A environment. Check out this article from Axios for more - https://lnkd.in/giUkjqmh #mergersandacquisitions #privateequity #healthtech #innovation #manda #venturecapital #foleyforward #garage2global Foley & Lardner LLP, Natasha Allen, Eric Chow, Brandee Diamond, Alicia Dorner, Lyman Thai, Tiaan De Nysschen, Alidad Vakili, André Thiollier

As the secondary market continues to grow, the healthcare sector seems to be left out of the conversation. As we conclude this series on VC Secondaries, Michael Boggs, a co-founded of Revelation Partners, provides his insights. Revelation manages over $1.5 billion, making them the largest dedicated provider targeting healthcare secondaries. Published on SecondaryLink. “Many of the companies we evaluate need to raise money. However, they typically have one or two investors that can no longer invest and support the company. We can serve as a catalyst to help bring together a financing. This helps the company solve their financing at the time we do our deal. As an example, we can price a primary round in conjunction with providing secondary liquidity thus catalyzing a financing event that de-risks the company. “ https://lnkd.in/gi7WnQHH

When we founded GHO Capital Partners LLP in 2014, we resolved to make healthcare better, faster, and more accessible for all. Since then, we have fulfilled this goal through the proactive development and optimisation of over twenty healthcare businesses across a number of specialist subsectors.   Together, we have written a blog discussing our investment strategy, success, and GHO’s vision for the future which you can now read by following the link below. 

We are pleased to release our review of M&A, private equity and venture capital activity across the UK healthcare sector in Q2 of 2024. Our report, which can be found below, highlights the most active sub-sectors, along with a month-by-month summary of the key deals across the market. #healthcare #privateequity #venturecapital #corporatefinance #investmentbanking #mergersandacquisitions #mergersacquisitionsdivestitures

Healthcare private equity deals dropped 28% in Q3 2023, per PitchBook. With 151 estimated deals, investors shift focus to smaller, targeted investments over big-budget projects. ASCs show one line growth deal and five add-on investments, signaling a nuanced investment landscape.

Private Equity Returns: Consistency of performance over the last decade is what attracts investors. Preqin analysis shows five members of the European Healthcare Investor Association (E.H.I.A.) in the top 10 performers: ➡️ Partners Group ➡️ Bain Capital ➡️ PAI Partners ➡️ Triton Partners ➡️ Ardian #privateequity #healthcare #lifesciences

📈⚕Our latest Healthcare Market Update, led by Andrew Davis, Kyle M., Eugene Yoon, Vasilios M. Kofitsas, and Gregory Benning, highlighted the robust activity in the private healthcare markets happening in Q4. Notably, eight companies have successfully secured over $20 million each in their venture rounds.     Discover more about the latest Q4 trends and gain insights from our experts here: https://bit.ly/3QK6ljM  

We are pleased to release our review of M&A, private equity and venture capital activity across the UK healthcare sector in Q1 of 2024. Our report, which can be found below, highlights the most active sub-sectors, along with a month-by-month summary of the key deals across the market. #healthcare #privateequity #venturecapital #corporatefinance #investmentbanking #mergersandacquisitions #mergersacquisitionsdivestitures

Marco Toni, Nicolas Wehrli, Gilles Pitschen and Pascal Hammerer have contributed to the Swiss chapter of the 2024 Healthcare M&A Chambers Global Practice Guide.   The guide provides the latest legal information on market trends, establishing healthcare start-ups, including early-stage financing and venture capital, IPOs and private sales, spin-offs, acquisition of listed companies, including stakebuilding, documentation, squeeze-out mechanisms, certain funds requirements and deal protection measures, regulatory requirements, including antitrust, foreign investment review and data privacy concerns, disclosure obligations, and duties of directors.   Click here to read the full chapter: https://lawand.tax/3RAAfah   #healthcare #lifesciences #Switzerland #lawandtax

Our latest insights on Healthcare M&A in Switzerland in the 2024 Chambers Global Practice Guide.